Organized by
Indiana University,
USA
Stanford Medicine,
USA
Indiana University,
USA
Weill Cornell Medicine,
USA.
University of Pittsburgh Medical Center,
USA
Indiana University Simon Comprehensive Cancer Center,
USA
Cleveland Clinic,
USA
Indiana University,
USA
Stanford University,
USA
The conference aims to enhance understanding of Oncpathology & Molecular Oncology, especially in prostate and renal cancers, through multidisciplinary perspectives, focusing on diagnostic advances, surgical strategies, molecular profiling, and therapeutic innovations to improve patient outcomes.
Delve into emerging technologies that are enhancing the accuracy and efficiency of cancer diagnostic methodologies.
Learn the structured incorporation of histopathological analysis alongside molecular profiling to facilitate a thorough and comprehensive oncologic evaluation.
Advance the implementation of personalized oncology approaches informed by molecular characteristics and individual patient profiles.
International collaboration and academic exchange to strengthen multidisciplinary efforts in cancer research and care.
Seamless translation of research findings into clinical practice to improve cancer diagnosis, treatment, and patient outcomes.
The 3rd International Conference on Oncopathology & Molecular Oncology, organized by the International Association for Integrated Oncology (IAIO), seeks to convene global experts to advance cancer diagnostics and therapeutics.
Modern Imaging in Early Metastatic Prostate Cancer
Gain insights on advanced imaging techniques for accurate early detection and staging of metastatic prostate cancer.
Castration-Resistant Prostate Cancer Phenotypes
Learn about diverse castration-resistant prostate cancer types and their clinical implications.
Surgical Management of Oligometastatic Prostate Cancer
Exploring surgical options, including palliative procedures for advanced prostate cancer cases.
Therapeutic Updates in Castration-Resistant Prostate Cancer
Reviewing current and emerging treatment modalities for castration-resistant prostate cancer.
Variant Morphologies of Renal Cell Carcinoma
Identifying clinically significant aggressive histologic subtypes of renal cancer.
Surgical Management of Advanced Renal Cancer
Evaluating consolidative and cytoreductive surgical strategies in advanced disease.
Adjuvant Therapy and New Treatments for Advanced Renal Cancer
Discussing the role of adjuvant therapies and novel treatment approaches in advanced renal carcinoma.